Warning: The NCBI web site requires JavaScript to function. more...
Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding.
Klitgaard T, Tabanera y Palacios R, Boffard KD, Iau PT, Warren B, Rizoli S, Rossaint R, Kluger Y, Riou B; NovoSeven Trauma Study Group.
Crit Care. 2006;10(4):R104.
Related citations
The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage.
Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B; NovoSeven Trauma Study Group.
Transfusion. 2009 Dec;49 Suppl 5:240S-7S.
Pharmacokinetics and pharmacodynamics of recombinant factor VIIa.
Lindley CM, Sawyer WT, Macik BG, Lusher J, Harrison JF, Baird-Cox K, Birch K, Glazer S, Roberts HR.
Clin Pharmacol Ther. 1994 Jun;55(6):638-48.
Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials.
Boffard KD, Riou B, Warren B, Choong PI, Rizoli S, Rossaint R, Axelsen M, Kluger Y; NovoSeven Trauma Study Group.
J Trauma. 2005 Jul;59(1):8-15; discussion 15-8.
Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials.
Rizoli SB, Boffard KD, Riou B, Warren B, Iau P, Kluger Y, Rossaint R, Tillinger M; NovoSeven Trauma Study Group.
Crit Care. 2006;10(6):R178.
Recombinant activated coagulation factor VII and bleeding trauma patients.
Rizoli SB, Nascimento B Jr, Osman F, Netto FS, Kiss A, Callum J, Brenneman FD, Tremblay L, Tien HC.
J Trauma. 2006 Dec;61(6):1419-25.
Recombinant activated factor VII in spinal surgery: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial.
Sachs B, Delacy D, Green J, Graham RS, Ramsay J, Kreisler N, Kruse P, Khutoryansky N, Hu SS.
Spine (Phila Pa 1976). 2007 Oct 1;32(21):2285-93.
Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
Martinowitz U, Kenet G, Lubetski A, Luboshitz J, Segal E.
Can J Anaesth. 2002 Dec;49(10):S15-20.
The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage in blunt trauma.
Geeraedts LM Jr, Kamphuisen PW, Kaasjager HA, Verwiel JM, van Vugt AB, Frölke JP.
Injury. 2005 Apr;36(4):495-500. Epub 2004 Dec 8.
Comparison of coagulant activity of factor VII and activated factor VII activity assays when used for determination of recombinant activated factor VII levels in plasma.
Scharling B, Nielsen GG, Klitgaard T, Skovsted TA, Møss J, Segel S, Larsen LF.
Blood Coagul Fibrinolysis. 2007 Oct;18(7):677-84.
Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency.
Berrettini M, Mariani G, Schiavoni M, Rocino A, Di Paolantonio T, Longo G, Morfini M.
Haematologica. 2001 Jun;86(6):640-5.
Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
Brandsborg S, Sørensen B, Poulsen LH, Ingerslev J.
Blood Coagul Fibrinolysis. 2006 Jun;17(4):241-9.
Overview of the human pharmacokinetics of recombinant activated factor VII.
Klitgaard T, Nielsen TG.
Br J Clin Pharmacol. 2008 Jan;65(1):3-11. Epub 2007 Oct 24.
Control of bleeding in children with Dengue hemorrhagic fever using recombinant activated factor VII: a randomized, double-blind, placebo-controlled study.
Chuansumrit A, Wangruangsatid S, Lektrakul Y, Chua MN, Zeta Capeding MR, Bech OM; Dengue Study Group.
Blood Coagul Fibrinolysis. 2005 Nov;16(8):549-55.
The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
Udy A, Vaghela M, Lawton G, Sigston P.
Anaesthesia. 2005 Jun;60(6):613-6.
Population pharmacokinetics of recombinant factor VIIa in volunteers anticoagulated with acenocoumarol.
Girard P, Nony P, Erhardtsen E, Delair S, Ffrench P, Dechavanne M, Boissel JP.
Thromb Haemost. 1998 Jul;80(1):109-13.
Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation.
Pihusch M, Bacigalupo A, Szer J, von Depka Prondzinski M, Gaspar-Blaudschun B, Hyveled L, Brenner B; F7BMT-1360 Trial Investigators.
J Thromb Haemost. 2005 Sep;3(9):1935-44.
Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial.
Kluger Y, Riou B, Rossaint R, Rizoli SB, Boffard KD, Choong PI, Warren B, Tillinger M.
Crit Care. 2007;11(4):R85.
Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia A.
Villar A, Aronis S, Morfini M, Santagostino E, Auerswald G, Thomsen HF, Erhardtsen E, Giangrande PL.
Haemophilia. 2004 Jul;10(4):352-9.
"Low-dose" recombinant activated factor VII results in less blood and blood product use in traumatic hemorrhage.
Harrison TD, Laskosky J, Jazaeri O, Pasquale MD, Cipolle M.
J Trauma. 2005 Jul;59(1):150-4.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on